Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9270748 | Journal of Infection | 2005 | 7 Pages |
Abstract
Underlying cancers, most commonly leukaemias and gastrointestinal tumors, were present in one-third of patients enrolled in this study of invasive candidiasis. Overall, 70% of caspofungin-treated and 56% of amphotericin B-treated cancer patients responded favorably. Response rates were lower for neutropenic leukaemic patients than for non-neutropenic patients with solid tumors in both treatment groups.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Mark J. DiNubile, Darcy Hille, Carole A. Sable, Nicholas A. Kartsonis,